Research Article

Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
  • Tuba Damar Çakırca
  • Tansu Yamazhan
  • Esra Yüksekkaya
  • Fethiye Akgül
  • Behice Kurtaran
  • Ömer Karaşahin
  • Oğuz Karabay
  • Gülten Ünlü
  • İlkay Nur Can
  • Hüsnü Pullukçu
  • Yeşim Taşova
  • Süheyla Kömür
  • Yeşim Yıldız
  • Çiğdem Mermutluoğlu
  • Yakup Demir
  • Mustafa Kemal Çelen
Viral Hepat J 2023; 29: 58-63 DOI: 10.4274/vhd.galenos.2023.2023-5-2
The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up
  • Murat Pekgöz
  • Nevin İnce
Viral Hepat J 2021; 27: 124-130 DOI: 10.4274/vhd.galenos.2021.2021-6-1

Letter to the Editor

Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?
  • Ergenekon KARAGÖZ
  • Vedat TURHAN
  • Asim ÜLÇAY
  • Alpaslan TANOĞLU
  • Hakan ERDEM
Viral Hepat J 2015; 21: 62-64 DOI: 10.4274/vhd.33042